Given our finding that non-NE SCLC presents with elevated ACSL4 expression and a ferroptosis-prone lipidome, it is tempting to speculate whether targeting of MEK5/ERK5 or the mevalonate pathway induces a partially ferroptotic cell death in non-NE SCLC. This evidence concerns the gene MAP2K5 and small cell lung carcinoma.